2008 | 2007 | 2006 | 2005 | 2004
11/07/05 Othera Pharmaceuticals Initiates Phase 2 Clinical Trial for OT-551 in Cataract Prevention
10/12/05 Othera Pharmaceuticals Elects Hans Mueller to Board
5/25/05 Othera Pharmaceuticals Announces Results from First Human Phase I Trial for OT-551
